Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
279.73
-1.29 (-0.46%)
Apr 19, 2024, 4:00 PM EDT - Market closed

Company Description

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.

It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories.

The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers.

Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories logo
Country United States
Founded 1952
Industry Medical Devices
Sector Healthcare
Employees 8,030
CEO Dr. Andrew J. Last Ph.D.

Contact Details

Address:
1000 Alfred Nobel Drive
Hercules, California 94547
United States
Phone (510) 724-7000
Website bio-rad.com

Stock Details

Ticker Symbol BIO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000012208
CUSIP Number 090572207
ISIN Number US0905722072
Employer ID 94-1381833
SIC Code 3826

Key Executives

Name Position
Norman D. Schwartz Chairman, Chief Executive Officer, President and Principal Financial Officer
Dr. Andrew J. Last Ph.D. Executive Vice President and Chief Operating Officer
Dr. Simon May Executive Vice President and President of the Life Science Group
Tania DeVilliers Senior Director, Corporate Controller and Interim Principal Accounting Officer
Yong Chung Vice President of Investor Relations
Timothy S. Ernst Executive Vice President, General Counsel and Secretary
Matthew Werner Senior Vice President and Chief Compliance and Privacy Officer
Colleen Corey Executive Vice President of Global Human Resources
Michael Crowley Executive Vice President of Global Commercial Operations
Lee Boyd Senior Vice President of Global Commercial Operations - Asia Pacific

Latest SEC Filings

Date Type Title
Apr 10, 2024 8-K Current Report
Mar 27, 2024 DEF 14A Other definitive proxy statements
Mar 27, 2024 ARS Filing
Mar 20, 2024 8-K Current Report
Mar 11, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 28, 2024 144 Filing
Feb 27, 2024 144 Filing
Feb 27, 2024 144 Filing
Feb 21, 2024 8-K Current Report
Feb 16, 2024 10-K Annual Report